Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial.
J Perinatol
; 43(5): 653-658, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2312155
ABSTRACT
OBJECTIVE:
Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDYDESIGN:
We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery.RESULT:
The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the studyCONCLUSION:
The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Drug-Related Side Effects and Adverse Reactions
/
COVID-19
Type of study:
Experimental Studies
/
Randomized controlled trials
Limits:
Humans
/
Infant
Language:
English
Journal:
J Perinatol
Journal subject:
Perinatology
Year:
2023
Document Type:
Article
Affiliation country:
S41372-022-01592-2
Similar
MEDLINE
...
LILACS
LIS